PolarityTE: Funding, Investors & Team (Oct 2026)
PolarityTE is dedicated to revolutionizing patient care through the discovery, creation, and advancement of regenerative tissue products and biomaterials in the fields of medicine, biomedical engineering, and material sciences. Instead of using artificial materials in lab settings, PolarityTE utilizes the patient's own tissue and body to facilitate the regenerative process. By utilizing a small piece of the patient's own healthy tissue, the company produces a versatile and self-sustaining product that aims to regenerate specific tissues. PolarityTE's innovative approach is designed to enhance and accelerate the healing process through natural tissue growth.
PolarityTE has raised $20.5M across 2 funding rounds on record, the most recent an undisclosed round of $12.5M announced in May 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
PolarityTE Company Profile and Key Stats
Latest funding round on record: May 2024.
PolarityTE Funding Rounds
PolarityTE raised $8.0M in a Post-IPO Equity announced in Jun 2022.
1.9 years later, an undisclosed round of $12.5M was announced in May 2024.
PolarityTE Founders and Leadership Team
No contact details are on record for this team yet.
PolarityTE Funding Compared to Other Biotechnology Startups
PolarityTE's latest round of $12.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PolarityTE in Biotechnology and Salt Lake City
Companies Similar to PolarityTE
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
PolarityTE Funding FAQs
What does PolarityTE do?
PolarityTE is dedicated to revolutionizing patient care through the discovery, creation, and advancement of regenerative tissue products and biomaterials in the fields of medicine, biomedical engineering, and material sciences. Instead of using artificial materials in lab settings, PolarityTE utilizes the patient's own tissue and body to facilitate the regenerative process. By utilizing a small piece of the patient's own healthy tissue, the company produces a versatile and self-sustaining product that aims to regenerate specific tissues. PolarityTE's innovative approach is designed to enhance and accelerate the healing process through natural tissue growth.
How much funding has PolarityTE raised?
PolarityTE has raised $20.5M across 2 rounds on record. The most recent is an undisclosed round of $12.5M announced in May 2024.
When did PolarityTE last raise funding?
PolarityTE's most recent funding round on record is an undisclosed round of $12.5M, announced in May 2024.
Who founded PolarityTE?
FundedIQ lists Denver Lough (Founder) at PolarityTE.
Who is the CEO of PolarityTE?
Richard Hague is listed as CEO at PolarityTE.
Where is PolarityTE headquartered?
PolarityTE is based in Salt Lake City, Utah, United States.
How many employees does PolarityTE have?
PolarityTE is in the 11-50 employee band.
How does PolarityTE's funding compare to other Biotechnology startups?
PolarityTE's latest round of $12.5M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's PolarityTE Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PolarityTE is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.